Steven M Wexler, MD - Medicare Emergency Medicine in Putnam, CT

Steven M Wexler, MD is a medicare enrolled "Emergency Medicine" physician in Putnam, Connecticut. He graduated from medical school in 1993 and has 31 years of diverse experience with area of expertise as Emergency Medicine. He is a member of the group practice Nes Medical Services Of Northern Connecticut, P.c., Lakes/national Emergency Physicians Inc and his current practice location is 320 Pomfret St, Putnam, Connecticut. You can reach out to his office (for appointments etc.) via phone at (860) 928-6541.

Steven M Wexler is licensed to practice in Connecticut (license number 038185) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1932173994.

Contact Information

Steven M Wexler, MD
320 Pomfret St,
Putnam, CT 06260-1836
(860) 928-6541
(860) 963-6368



Physician's Profile

Full NameSteven M Wexler
GenderMale
SpecialityEmergency Medicine
Experience31 Years
Location320 Pomfret St, Putnam, Connecticut
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Steven M Wexler graduated from medical school in 1993
  NPI Data:
  • NPI Number: 1932173994
  • Provider Enumeration Date: 02/15/2006
  • Last Update Date: 10/31/2007
  Medicare PECOS Information:
  • PECOS PAC ID: 7113948258
  • Enrollment ID: I20051228000304

Medical Identifiers

Medical identifiers for Steven M Wexler such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1932173994NPI-NPPES
P00273066OtherRAILROAD

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207P00000XEmergency Medicine 038185 (Connecticut)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Holyoke Medical CenterHolyoke, MAHospital
Day Kimball HospitalPutnam, CTHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Nes Medical Services Of Northern Connecticut, P.c.731584396823
Lakes/national Emergency Physicians Inc923412624418

News Archive

S1P1R variation may cause differential patient responses to fingolimod treatment

Multiple sclerosis (MS) is an autoimmune disorder that results in demyelination of neurons. The FDA-approved drug fingolimod (Gilenya, FTY-720) modulates signaling by the bioactive lipid sphingosine-1-phosphate (S1P), which is linked to MS pathogenesis.

New extra potent sunscreens in the pipeline

Sunscreens are touted to protect your skin from the harmful ultraviolet rays of the sun. However scientists are now studying whether a good sunscreen protects your skin even after your skin is no longer exposed to the sun? This study is undertaken because of the alarming rise in malignant melanoma, a form of skin cancer that is linked to the sun's UV rays. Malignant melanoma is the most common cancer in Australia and Queensland tops all other places in the world when it comes to incidence of this skin cancer.

Capstone Therapeutics reaches overall progress in AZX100 Phase 2a clinical trials for keloid scarring

Capstone Therapeutics announced today that participating subjects have reached the planned twelve-month timepoint in the first of its two ongoing AZX100 Phase 2a clinical trials in keloid scarring. Data analysis for these subjects is underway. Per protocol and the original clinical development plan, results of the two keloid scarring trials will be pooled for analytical purposes and are scheduled for release during 4Q2010.

Loyola surgical oncologist removes high-grade liver tumor

The cancerous tumor in Marcus Muhich's liver weighed 8 pounds and was nearly a foot across. Doctors at three major academic medical centers in the Midwest told Muhich his high-grade tumor was inoperable.

New study shows homebound status of older victims of 2011 Great East Japan Earthquake

A new study, published online in the journal Age and Ageing today, shows that the homebound status of adults over the age of 65 in the aftermath of the 2011 Great East Japan Earthquake is still a serious public health concern. Of 2,327 older adults surveyed, approximately 20% were found to be homebound.

Read more Medical News

› Verified 7 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Steven M Wexler allows following entities to bill medicare on his behalf.
Entity NameNes Medical Services Of Northern Connecticut, P.c.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1447231865
PECOS PAC ID: 7315843968
Enrollment ID: O20040112000084

News Archive

S1P1R variation may cause differential patient responses to fingolimod treatment

Multiple sclerosis (MS) is an autoimmune disorder that results in demyelination of neurons. The FDA-approved drug fingolimod (Gilenya, FTY-720) modulates signaling by the bioactive lipid sphingosine-1-phosphate (S1P), which is linked to MS pathogenesis.

New extra potent sunscreens in the pipeline

Sunscreens are touted to protect your skin from the harmful ultraviolet rays of the sun. However scientists are now studying whether a good sunscreen protects your skin even after your skin is no longer exposed to the sun? This study is undertaken because of the alarming rise in malignant melanoma, a form of skin cancer that is linked to the sun's UV rays. Malignant melanoma is the most common cancer in Australia and Queensland tops all other places in the world when it comes to incidence of this skin cancer.

Capstone Therapeutics reaches overall progress in AZX100 Phase 2a clinical trials for keloid scarring

Capstone Therapeutics announced today that participating subjects have reached the planned twelve-month timepoint in the first of its two ongoing AZX100 Phase 2a clinical trials in keloid scarring. Data analysis for these subjects is underway. Per protocol and the original clinical development plan, results of the two keloid scarring trials will be pooled for analytical purposes and are scheduled for release during 4Q2010.

Loyola surgical oncologist removes high-grade liver tumor

The cancerous tumor in Marcus Muhich's liver weighed 8 pounds and was nearly a foot across. Doctors at three major academic medical centers in the Midwest told Muhich his high-grade tumor was inoperable.

New study shows homebound status of older victims of 2011 Great East Japan Earthquake

A new study, published online in the journal Age and Ageing today, shows that the homebound status of adults over the age of 65 in the aftermath of the 2011 Great East Japan Earthquake is still a serious public health concern. Of 2,327 older adults surveyed, approximately 20% were found to be homebound.

Read more Medical News

› Verified 7 days ago

Entity NameDay Kimball Medical Group Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1376813972
PECOS PAC ID: 1557514411
Enrollment ID: O20130102000091

News Archive

S1P1R variation may cause differential patient responses to fingolimod treatment

Multiple sclerosis (MS) is an autoimmune disorder that results in demyelination of neurons. The FDA-approved drug fingolimod (Gilenya, FTY-720) modulates signaling by the bioactive lipid sphingosine-1-phosphate (S1P), which is linked to MS pathogenesis.

New extra potent sunscreens in the pipeline

Sunscreens are touted to protect your skin from the harmful ultraviolet rays of the sun. However scientists are now studying whether a good sunscreen protects your skin even after your skin is no longer exposed to the sun? This study is undertaken because of the alarming rise in malignant melanoma, a form of skin cancer that is linked to the sun's UV rays. Malignant melanoma is the most common cancer in Australia and Queensland tops all other places in the world when it comes to incidence of this skin cancer.

Capstone Therapeutics reaches overall progress in AZX100 Phase 2a clinical trials for keloid scarring

Capstone Therapeutics announced today that participating subjects have reached the planned twelve-month timepoint in the first of its two ongoing AZX100 Phase 2a clinical trials in keloid scarring. Data analysis for these subjects is underway. Per protocol and the original clinical development plan, results of the two keloid scarring trials will be pooled for analytical purposes and are scheduled for release during 4Q2010.

Loyola surgical oncologist removes high-grade liver tumor

The cancerous tumor in Marcus Muhich's liver weighed 8 pounds and was nearly a foot across. Doctors at three major academic medical centers in the Midwest told Muhich his high-grade tumor was inoperable.

New study shows homebound status of older victims of 2011 Great East Japan Earthquake

A new study, published online in the journal Age and Ageing today, shows that the homebound status of adults over the age of 65 in the aftermath of the 2011 Great East Japan Earthquake is still a serious public health concern. Of 2,327 older adults surveyed, approximately 20% were found to be homebound.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Steven M Wexler is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Steven M Wexler, MD
Po Box 409010,
Atlanta, GA 30384-9010

Ph: (800) 377-8721
Steven M Wexler, MD
320 Pomfret St,
Putnam, CT 06260-1836

Ph: (860) 928-6541

News Archive

S1P1R variation may cause differential patient responses to fingolimod treatment

Multiple sclerosis (MS) is an autoimmune disorder that results in demyelination of neurons. The FDA-approved drug fingolimod (Gilenya, FTY-720) modulates signaling by the bioactive lipid sphingosine-1-phosphate (S1P), which is linked to MS pathogenesis.

New extra potent sunscreens in the pipeline

Sunscreens are touted to protect your skin from the harmful ultraviolet rays of the sun. However scientists are now studying whether a good sunscreen protects your skin even after your skin is no longer exposed to the sun? This study is undertaken because of the alarming rise in malignant melanoma, a form of skin cancer that is linked to the sun's UV rays. Malignant melanoma is the most common cancer in Australia and Queensland tops all other places in the world when it comes to incidence of this skin cancer.

Capstone Therapeutics reaches overall progress in AZX100 Phase 2a clinical trials for keloid scarring

Capstone Therapeutics announced today that participating subjects have reached the planned twelve-month timepoint in the first of its two ongoing AZX100 Phase 2a clinical trials in keloid scarring. Data analysis for these subjects is underway. Per protocol and the original clinical development plan, results of the two keloid scarring trials will be pooled for analytical purposes and are scheduled for release during 4Q2010.

Loyola surgical oncologist removes high-grade liver tumor

The cancerous tumor in Marcus Muhich's liver weighed 8 pounds and was nearly a foot across. Doctors at three major academic medical centers in the Midwest told Muhich his high-grade tumor was inoperable.

New study shows homebound status of older victims of 2011 Great East Japan Earthquake

A new study, published online in the journal Age and Ageing today, shows that the homebound status of adults over the age of 65 in the aftermath of the 2011 Great East Japan Earthquake is still a serious public health concern. Of 2,327 older adults surveyed, approximately 20% were found to be homebound.

Read more News

› Verified 7 days ago


Emergency Medicine Doctors in Putnam, CT

Duc H. Le, M.D.
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 320 Pomfret St, Putnam, CT 06260
Phone: 860-928-6541    Fax: 860-963-6368
Nathaniel Manning, M.D.
Emergency Medicine
Medicare: Not Enrolled in Medicare
Practice Location: 320 Pomfret St, Putnam, CT 06260
Phone: 860-928-6541    Fax: 860-963-6368
Debra A. Campbell, D.O.
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 320 Pomfret St, Putnam, CT 06260
Phone: 860-928-6541    Fax: 860-963-6368
Teresa A. Allen, M.D.
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 320 Pomfret St, Putnam, CT 06260
Phone: 860-928-6541    Fax: 860-963-6368
John G. Boras, M.D.
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: 320 Pomfret St, Putnam, CT 06260
Phone: 860-928-6541    Fax: 860-963-6368
Wendy A. Witt, M.D.
Emergency Medicine
Medicare: May Accept Medicare Assignments
Practice Location: 320 Pomfret St, Putnam, CT 06260
Phone: 860-928-6541    Fax: 860-963-6368

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.